The adult and pediatric hemoconcentrators market is anticipated to record a CAGR of 3% during the forecast period, to reach a valuation of US$ 14.1 Mn by 2027.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2027) | US$ 14.1 Million |
| Projected Growth Rate (2022 to 2032) | 3% |
Sales of adult and pediatric hemoconcentrators are expected to rise as perfusionists and surgeons are increasingly relying on hemoconcentrators to maintain higher hematocrit levels during cardiopulmonary surgery. In addition to this, demand for adult and pediatric hemoconcentrators is rising on account of heart diseases becoming more common over the world.
The increasing frequency of cardiovascular disorders in low-income nations has prompted an emphasis on cardiac care, which is projected to contribute to the growth of the adult and pediatric hemoconcentrators market share.
The report sheds light on the factors improving the sales of adult and pediatric hemoconcentrators and, in turn, the opportunities for the market players. However, the adult and pediatric hemoconcentrators market also face some challenges, limiting theadult and pediatric hemoconcentrators market share from reaching its potential.
Some of the key adult and pediatric hemoconcentrators maret trends promoting the demand for adult and pediatric hemoconcentrators include growing public knowledge of the virus's harmful effects on organs such as the lungs and heart, which may aid a faster industry recovery from the pandemic in the near future.
The growing number of cardiac bypass surgery patients and the increased need for technologically enhanced fluid management products are driving the global adult and pediatric hemoconcentrators market.
Other factors projected to enhance market expansion include various government efforts, an aging population, and more research and development activities. On the other hand, the availability of hemoconcentration alternatives, the numerous difficulties connected with hemoconcentration, and a lack of knowledge are all crucial issues that could slow the global market's growth.
Surgeons have preferred the hemoconcentration method for controlling hemodilution during cardiopulmonary surgery. This process also helps maintain higher hematocrit levels and reduces the need for additional blood products during and after bypass surgery. The usage of hemoconcentration during cardiac bypass surgery is increasing continuously, and so is the demand for adult and pediatric hemoconcentrators.
The hemoconcentrators help decrease the risk after post-operative bleeding and reduce the need for homologous blood and blood products, leading to a rise indemand for adult and pediatric hemoconcentrators. The hemoconcentrators come with different sized and glycerine-free polysulfone membranes for excellent biocompatibility. It also helps to easy insertion and maintain higher hematocrit and fluid levels.
According to the WHO, approximately 17.3 million people died from CVDs in 2008 globally, and the number is expected to increase by 23.6 million by 2030. Globally, with the increasing number of patients with cardiac diseases, demand a cost-effective method of processing hemodiluted blood.
The aging population is increasing, which results in the sales of adult and pediatric hemoconcentrators also rising.
An increasing number of patients with cardiac bypass surgery, rising demand for technologically advanced fluid management products, increasing research and development activities, government initiatives, and a growing aging population are some of the factors that drive the sales of adult and pediatric hemoconcentrators.
However, the availability of substitutes for hemoconcentrators acts as an inhibitor for this market, which might limit the sales of adult and pediatric hemoconcentrators.
The global adult and pediatric hemoconcentrators market are expected to register a healthy CAGR for the forecast period with a stable demand for adult and pediatric hemoconcentrators. Depending on geographic regions, the global adult and pediatric hemoconcentrators market are segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
North America, followed by Europe, dominates the sales of adult and pediatric hemoconcentrators due to the increasing number of patients with cardiac bypass, growing aging population, developed healthcare infrastructure and growing demand for adult and pediatric hemoconcentrators in these regions.
Asia Pacific is the fastest emerging market with high sales of adult and pediatric hemoconcentrators due to the growing patient population with cardiac diseases, increasing awareness about advanced fluid management products available in the market, developing healthcare infrastructure and rising government spending in the healthcare industry in this region.
Some of the key market players in the global adult and pediatric hemoconcentrators market are Sorin Group, Medivators Inc., Terumo Cardiovascular Systems Corporation, MAQUET Holding B.V. & Co. K.G. and Andocor Nv.
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 3% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Product Type, End User, Region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | Medivators Inc., Andocor Nv, MAQUET Holding B.V. & Co. KG, Terumo Cardiovascular Systems Corporation, and Sorin Group. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The adult and pediatric hemoconcentrators market is likely to register a CAGR of 3% during the forecast period.
Key players holding substantial adult and pediatric hemoconcentrators market share include Medivators Inc., Andocor Nv, MAQUET Holding B.V. & Co. KG, Terumo Cardiovascular Systems Corporation, and Sorin Group.
As per the analysis, the adult and pediatric hemoconcentrators market share is likely to be US$ 14.1 Mn by 2027.
Explore Similar Insights
Adult and Pediatric Hemoconcentrators Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
